Simplex Trading’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17
Closed 10215
2023
Q4
$0 Buy
17
+11
+183% +$130 ﹤0.01% 10124
2023
Q3
$0 Sell
6
-32
-84% -$595 ﹤0.01% 10148
2023
Q2
$0 Buy
38
+35
+1,167% +$1.02K ﹤0.01% 10219
2023
Q1
$0 Sell
3
-31
-91% -$1.9K ﹤0.01% 10424
2022
Q4
$2K Buy
34
+3
+10% +$201 ﹤0.01% 8700
2022
Q3
$2K Buy
+31
New +$3.24K ﹤0.01% 9418

Other funds holding OMIC

Simplex Trading's OMIC Position: Q1 2024 in Review

Simplex Trading sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2024, closing a stake of 17 shares.

Simplex Trading first reported a position in OMIC in Q3 2022 and held it in 6 quarters. The position peaked at $2K in Q4 2022. 42 funds tracked by Wall St. Rank hold OMIC as of Q1 2024.

  • Simplex Trading reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 17 Singular Genomics Systems, Inc. Common Stock shares in Q1 2024.
  • Simplex Trading first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Simplex Trading's Singular Genomics Systems, Inc. Common Stock position peaked at $2K in Q4 2022.
  • 42 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.